{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:5757",
      "entity_text" : "estradiol",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-0711" ]
    }
  },
  "verbose_text" : "Additional COS improvements include the use of GnRHa for ovulation trigger, which further reduces estradiol levels after oocyte pick up, minimizing further the risk of ovarian hyperstimulation, and the random-start initiation, which enables women with cancer to initiate promptly the COS treatment, irrespective of menstrual cycle phase.",
  "reading_complete" : "2020-08-04T18:43:34Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T18:41:55Z",
  "trigger" : "levels",
  "evidence" : [ "estradiol levels" ],
  "pmc_id" : "7192532",
  "score" : 0
}